By SIMON CONSTABLE
Shares of struggling German health-care and chemical giant Bayer revived a bit on Thursday as the company got at least a temporary reprieve from a huge jury award that held its weed killer Roundup liable for a plaintiff’s cancer.
There is likely to be more positive news for long-term investors, as this and related cases against Roundup proceed through the court system. Read more here.
Daniel Case, CC BY-SA 3.0, via Wikimedia Commons
No comments:
Post a Comment